Severe lamotrigine toxicosis in a dog

Danielle Sawyer, Kathryn Gates Emergency and Critical Care Department, Advanced Critical Care and Emergency Specialty Services, Culver City, CA, USA Objective: The objective of this study was to describe a case of severe lamotrigine toxicosis in a dog, which was successfully treated using minimal me...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sawyer D, Gates K
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/0537d6a98d874f0aa2995c0113a11f40
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0537d6a98d874f0aa2995c0113a11f40
record_format dspace
spelling oai:doaj.org-article:0537d6a98d874f0aa2995c0113a11f402021-12-02T01:41:32ZSevere lamotrigine toxicosis in a dog2230-2034https://doaj.org/article/0537d6a98d874f0aa2995c0113a11f402017-04-01T00:00:00Zhttps://www.dovepress.com/severe-lamotrigine-toxicosis-in-a-dog-peer-reviewed-article-VMRRhttps://doaj.org/toc/2230-2034Danielle Sawyer, Kathryn Gates Emergency and Critical Care Department, Advanced Critical Care and Emergency Specialty Services, Culver City, CA, USA Objective: The objective of this study was to describe a case of severe lamotrigine toxicosis in a dog, which was successfully treated using minimal medical interventions. Case summary: A 7-month-old male, intact, Labrador mix was evaluated because of acute onset of vomiting, rigidity, and dull mentation after ingesting lamotrigine tablets. The estimated oral dose that had been ingested was 278 mg/kg (611.6 mg/lb). Physical examination was unremarkable other than abnormalities noted in the cardiovascular and neurological systems. Neurological examination revealed dull mentation, vertical nystagmus, four-legged extensor limb rigidity, and alligator rolling. Cardiovascular examination revealed pale pink mucous membranes and multifocal ventricular tachycardia. Intravenous (IV) fluids were started at three times maintenance (180 mL/kg/day). Methocarbamol (100 mg/kg [220 mg/lb], rectally) and lidocaine (2 mg/kg [4.4 mg/lb, IV]) were administered. Twenty-four and seventy-two hours after presentation, the dog was clinically normal with no ventricular tachycardia being noted. Conclusion: Lamotrigine (6-[2,3-dichlorophenyl]-1,2,4-triazine-3,5-diamine) is an anticonvulsant medication used in humans, which inhibits voltage-gated sodium channels. The clinical success of this case suggests that administration of only methocarbamol for the neurologic effects and lidocaine for the arrhythmias, as well as supportive IV fluid therapy, could be a successful treatment strategy for dogs, even with severe lamotrigine toxicosis. Keywords: arrhythmia, toxicity, multifocal ventricular tachycardia, poisonSawyer DGates KDove Medical PressarticleArrhythmiaToxicityMultifocal Ventricular TachycardiaPoisonVeterinary medicineSF600-1100ENVeterinary Medicine: Research and Reports, Vol Volume 8, Pp 27-30 (2017)
institution DOAJ
collection DOAJ
language EN
topic Arrhythmia
Toxicity
Multifocal Ventricular Tachycardia
Poison
Veterinary medicine
SF600-1100
spellingShingle Arrhythmia
Toxicity
Multifocal Ventricular Tachycardia
Poison
Veterinary medicine
SF600-1100
Sawyer D
Gates K
Severe lamotrigine toxicosis in a dog
description Danielle Sawyer, Kathryn Gates Emergency and Critical Care Department, Advanced Critical Care and Emergency Specialty Services, Culver City, CA, USA Objective: The objective of this study was to describe a case of severe lamotrigine toxicosis in a dog, which was successfully treated using minimal medical interventions. Case summary: A 7-month-old male, intact, Labrador mix was evaluated because of acute onset of vomiting, rigidity, and dull mentation after ingesting lamotrigine tablets. The estimated oral dose that had been ingested was 278 mg/kg (611.6 mg/lb). Physical examination was unremarkable other than abnormalities noted in the cardiovascular and neurological systems. Neurological examination revealed dull mentation, vertical nystagmus, four-legged extensor limb rigidity, and alligator rolling. Cardiovascular examination revealed pale pink mucous membranes and multifocal ventricular tachycardia. Intravenous (IV) fluids were started at three times maintenance (180 mL/kg/day). Methocarbamol (100 mg/kg [220 mg/lb], rectally) and lidocaine (2 mg/kg [4.4 mg/lb, IV]) were administered. Twenty-four and seventy-two hours after presentation, the dog was clinically normal with no ventricular tachycardia being noted. Conclusion: Lamotrigine (6-[2,3-dichlorophenyl]-1,2,4-triazine-3,5-diamine) is an anticonvulsant medication used in humans, which inhibits voltage-gated sodium channels. The clinical success of this case suggests that administration of only methocarbamol for the neurologic effects and lidocaine for the arrhythmias, as well as supportive IV fluid therapy, could be a successful treatment strategy for dogs, even with severe lamotrigine toxicosis. Keywords: arrhythmia, toxicity, multifocal ventricular tachycardia, poison
format article
author Sawyer D
Gates K
author_facet Sawyer D
Gates K
author_sort Sawyer D
title Severe lamotrigine toxicosis in a dog
title_short Severe lamotrigine toxicosis in a dog
title_full Severe lamotrigine toxicosis in a dog
title_fullStr Severe lamotrigine toxicosis in a dog
title_full_unstemmed Severe lamotrigine toxicosis in a dog
title_sort severe lamotrigine toxicosis in a dog
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/0537d6a98d874f0aa2995c0113a11f40
work_keys_str_mv AT sawyerd severelamotriginetoxicosisinadog
AT gatesk severelamotriginetoxicosisinadog
_version_ 1718402879270682624